3-(dibutylamino)-4-phenoxy-5-sulfamoylbenzoic acid

N4,N4'-di(anthracen-1-yl)-N4,N4'-diphenyl-[1,1'-biphenyl]-4,4'-diamine

N4,N4'-bis(4'-(2H-benzo[d][1,2,3]triazol-2-yl)-[1,1'-biphenyl]-4-yl)-N4,N4'-diphenyl-[1,1'-biphenyl]-4,4'-diamine

6-(4'-(9H-carbazol-9-yl)-[1,1'-biphenyl]-4-yl)-3,11,11-triphenyl-3,4,6,11-tetrahydro-2H-benzo[4,5]indolo[3,2-a]acridine

7-(4'-(9H-carbazol-9-yl)-[1,1'-biphenyl]-4-yl)-12-(10,10-dimethyl-10H-spiro[anthracene-9,9'-fluoren]-2'-yl)-7,12-dihydrobenzo[b]naphtho[1,8-ef][1,4]diazepine

5-(4'-(9H-carbazol-9-yl)-[1,1'-biphenyl]-4-yl)-15,15-dimethyl-10-phenyl-10,15-dihydro-5H-benzo[c]indolo[3,2-a]acridine

N4,N4'-bis(4-(diphenylamino)phenyl)-N4-phenyl-N4'-(spiro[cyclohexane-1,9'-fluoren]-2'-yl)-[1,1'-biphenyl]-4,4'-diamine

N4,N4'-(naphthalene-2,7-diyl)bis(N4,N4',N4'-triphenyl-[1,1'-biphenyl]-4,4'-diamine)

Brivaracetam impurity 30

3-nitro-5-sulfamoylbenzoic acid

4-Phenoxy benzohydrazide

Palbociclib Succinic Acid Adduct

[3-[(Diethoxyphosphinyl)methyl]-4-nitrophenyl]sulfur pentafluoride

5-(4-(pentafluoromercapto)phenyl)octahydro-1H-4,7-methanoinden-5-ol

(2R,3S,6R)-2-(((tert-butyldimethylsilyl)oxy)methyl)-6-(tributylstannyl)-3-((triethylsilyl)oxy)dihydro-2H-pyran-4(3H)-one

(1R,4S,7S,E)-7-((tert-butyldimethylsilyl)oxy)-1-hydroxy-3-methylene-1-((2S,3S)-3-((R)-3-(tributylstannyl)-1-((triisopropylsilyl)oxy)but-3-en-1-yl)oxiran-2-yl)undec-9-en-4-yl benzoate

(2R,3R,4R,5R,6R)-4,5-bis(benzyloxy)-6-((benzyloxy)methyl)-2-(((2R,3R,4S,5R,6S)-3,4,5-tris(benzyloxy)-6-(tributylstannyl)tetrahydro-2H-pyran-2-yl)methoxy)tetrahydro-2H-pyran-3-ol

((2S,3R,4S,5R,6R)-3,4-bis(benzyloxy)-6-((benzyloxy)methyl)-5-(((2R,3R,4S,5R,6R)-3,4,5-tris(benzyloxy)-6-((benzyloxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)tributylstannane

(2R,3S,4R)-2-(acetoxymethyl)-5-((E)-2-cyclopropyl-1-(tributylstannyl)vinyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate

(2R,3S,4R)-2-(hydroxymethyl)-5-((E)-2-phenyl-1-(tributylstannyl)vinyl)-3,4-dihydro-2H-pyran-3,4-diol